Tenapanor for the Treatment of Pediatric Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Condition:   Irritable Bowel Syndrome With Constipation (IBS-C) Intervention:   Drug: Tenapanor Sponsor:   Ardelyx Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2023 Category: Research Source Type: clinical trials

Response of Irritable Bowel Syndrome to Abdominal Fat Reduction
Conditions:   Irritable Bowel Syndrome;   Obesity;   Abdominal Obesity Interventions:   Device: focused ultrasound;   Behavioral: Low Caloric Diet (LCD) and a low (FODMAPs) diet;   Other: aerobic exercise Sponsor:   Cairo University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 30, 2023 Category: Research Source Type: clinical trials

Response of Irritable Bowel Syndrome to Abdominal Fat Reduction
Conditions:   Irritable Bowel Syndrome;   Obesity;   Abdominal Obesity Interventions:   Procedure: focused ultrasound;   Behavioral: Low Caloric Diet (LCD) and a low (FODMAPs) diet;   Other: aerobic exercise Sponsor:   Cairo University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 30, 2023 Category: Research Source Type: clinical trials